Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Aegon Insurance Group

Article Abstract:

Aegon Insurance Group sales are likely to wane and as shares plunged 37% since January 2003 with the announcment of a 40% reduction in the proposed 2003 dividends. Investors are advised to avoid these shares until a sustained global recovery in the equity and credit markets occur.

Author: Pandolfi, Anthony P.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Netherlands, Forecasts, trends, outlooks, Financial management, Labor Distribution by Employer, Finance, Company investment, Investments, Statistics, Aegon Insurance Group, Company business forecast/projection, Company forecasts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


XL Capital Ltd

Article Abstract:

A comparative analysis of the company sales and financial details of XL Capital Ltd. from 1992 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.

Author: Pandolfi, Anthony P.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
INSURANCE CARRIERS, Bermuda, XL Capital Ltd., XL

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Insurance industry, Securities, Company sales and earnings, Company earnings/profit, Company securities
Similar abstracts:
  • Abstracts: ACE Ltd. XL Capital Ltd. John Hancock Financial Services Inc.
  • Abstracts: 21st Century Ins. 21st Century Insurance
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.